Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Textual)

v3.5.0.2
Commitments and Contingencies (Details Textual)
1 Months Ended 3 Months Ended
Jul. 09, 2015
USD ($)
Sep. 12, 2013
USD ($)
Jun. 17, 2016
USD ($)
Feb. 15, 1999
USD ($)
Sep. 30, 2016
ft²
Jul. 06, 2016
ft²
Commitments and Contingencies [Line Items]            
Area of Land | ft²           2,300
License Expiration Period       12 years    
License Costs   $ 50,000 $ 15,000 $ 12,500    
First Capital Lease Agreement [Member]            
Commitments and Contingencies [Line Items]            
Lease Expiration Period         3 years  
Second Capital Lease Agreement [Member]            
Commitments and Contingencies [Line Items]            
Lease Expiration Period         2 years  
Minimum [Member]            
Commitments and Contingencies [Line Items]            
License Costs     5,000      
Maximum [Member]            
Commitments and Contingencies [Line Items]            
License Costs     $ 20,000      
Licensor [Member]            
Commitments and Contingencies [Line Items]            
Area of Land | ft²         4,516  
Valeant Pharmaceuticals International Inc [Member] | Licensing Agreements [Member]            
Commitments and Contingencies [Line Items]            
Payments to Acquire Intangible Assets $ 1,000,000          
Proceeds from Sale of Intangible Assets $ 32,500,000